Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Human safety and efficacy [of TB-500] remain unclear, added Christine Bonarrigo, PharmD, a weight management clinical pharmacist at Tufts Medical Center
Where researchers do add compounds, they are usually pursuing a different axis entirely for example a GH-axis or metabolic peptide for goals KLOW does not target
In the sprawling world of peptide research, certain compounds generate a level of excitement that's impossible to ignore, and AHK-Cu is firmly in that category for 2026
[PMID: 16253281] PubMed record related to this compound for laboratory literature review
Zero Phase II or Phase III human trials have been completed for any indication
Testing includes: This level of testing gives you confidence in compound quality and consistency
US$ 22.58
US$ 28.73
US$ 23.28
US$ 24.32
US$ 28.68
